跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
臺北神經醫學中心
臺北醫學大學
網站
https://www.taipeineuro.org.tw/
概覽
指紋
網路
專家檔案
(145)
專案
(23)
研究成果
(3216)
指紋
查看啟用 臺北神經醫學中心 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Adverse Event
11%
Alcoholic Polyneuropathy
9%
Alzheimer's Disease
19%
Antidepressant
13%
Apoplexy
100%
Arm
10%
Artery
8%
Biological Marker
15%
Bipolar Disorder
33%
Bleeding
12%
Blood Clot Lysis
8%
Body Mass Index
9%
Brain Ischemia
41%
Brain Tumor
12%
Cardiovascular Disease
9%
Case-Control Study
14%
Cerebral Hemorrhage
18%
Clinical Trial
8%
Clinician
8%
Closed Head Injury
10%
Cognition
8%
Cognitive Defect
12%
Cohort Analysis
56%
Combination Therapy
8%
Computer Assisted Tomography
27%
Cross Sectional Study
8%
Depression
7%
Diabetes
16%
Diabetes Mellitus
12%
Diagnosis
12%
Disability
25%
Disease
48%
Drug Therapy
23%
Electrical Brain Stimulation
9%
Electrostimulation
8%
Epileptic Seizure
9%
Functional Electrical Stimulation
11%
Gamma Knife Radiosurgery
7%
Ganglioglioma
17%
Glioblastoma
20%
Hazard Ratio
32%
Headache
8%
Hip Fracture
8%
In Vitro
13%
Infarction
7%
Infection
7%
Injury
33%
International Classification of Impairments, Disabilities and Handicaps
9%
Knee
11%
Knee Osteoarthritis
14%
Leg
8%
Logistic Regression Analysis
13%
Lower Limb
8%
Magnetic Resonance Imaging
45%
Magnetic Resonance Imaging
9%
Major Depressive Episode
12%
Malignant Neoplasm
16%
Medicine
10%
Mesenchymal Stem Cell
8%
Meta-Analysis
67%
Metastatic Carcinoma
10%
Mortality Rate
10%
Motor Performance
11%
Neoplasm
41%
Network Meta-Analysis
8%
Neurologic Disease
11%
Nuclear Magnetic Resonance
8%
Obstructive Sleep Apnea
12%
Odds Ratio
25%
Osteoarthritis
12%
Outpatient
13%
Parkinson's Disease
25%
Pediatrics
14%
Percutaneous Vertebroplasty
10%
Placebo
13%
Population
7%
Prevalence
16%
Programmed Cell Death
10%
Proportional Hazards Model
11%
Quality of Life
14%
Radiation Therapy
15%
Randomized Controlled Trial
56%
Recurrent Disease
8%
Rehabilitation Engineering
30%
Resistance Training
10%
Retrospective Cohort Study
13%
Retrospective Study
8%
Sarcopenia
12%
Spinal Cord Injury
19%
Stereotactic Radiosurgery
9%
Supplementation
12%
Surgery
13%
Survival Rate
7%
Symptom
35%
Systematic Review
49%
Total Knee Arthroplasty
8%
Traumatic Brain Injury
40%
Typical Antipsychotic
8%
Upper Limb
11%
Visual Analog Scale
10%
Neuroscience
Adverse Effect
7%
Alzheimer's Disease
35%
Amyloid
11%
Antidepressant
21%
Antipsychotic
14%
Arterial Spin Labeling
6%
Arteriovenous Malformation
6%
Artificial Neural Network
10%
Aspirin
6%
Astrocyte
9%
Atrial Fibrillation
6%
Attention Deficit Hyperactivity Disorder
6%
Autophagy
10%
Behavior (Neuroscience)
19%
Bipolar Disorder
66%
Bipolar I Disorder
8%
Bipolar Mania
7%
Blood Brain Barrier
11%
Body Mass Index
13%
Brain Ischemia
82%
Brain Tumor
14%
Brain-Derived Neurotrophic Factor
9%
Cell Death
8%
Cell Line
5%
Cell Signaling
9%
Cerebral Hemorrhage
26%
Cerebrovascular Disease
8%
Closed Head Injury
15%
Clozapine
10%
Cognitive Disorders
35%
Cognitive Function
19%
Computed Tomography
9%
Dementia Praecox
61%
Depression
17%
Diabetes Mellitus
15%
Diffusion Tensor Imaging
11%
Dopamine Release
7%
Electrical Brain Stimulation
11%
Electroencephalography
6%
Excitability
5%
Face
5%
Fibromyalgia
12%
Fractional Anisotropy
6%
Functional Connectivity
10%
Functional Electrical Stimulation
6%
Functional Magnetic Resonance Imaging
12%
Glioblastoma Multiforme
11%
Heart Rate Variability
11%
Hematoma
6%
Hippocampus
8%
Impulsivity
6%
In Vitro
17%
In Vivo
21%
Ischemia
13%
Longitudinal Study
5%
Magnetic Resonance Imaging
31%
Magnetic Resonance Imaging
28%
Major Depressive Disorder
25%
Mental Disorder
11%
Mesenchymal Stem Cell
12%
Meta-Analysis
67%
Metabolic Pathway
11%
Middle Cerebral Artery
14%
Mild Cognitive Impairment
8%
Neural Network
10%
Neurodegenerative Disorder
8%
Neuroprotection
7%
Neuroprotective Agent
14%
Neurotrauma
81%
Obstructive Sleep Apnea
21%
Olanzapine
13%
Oxidative Stress
14%
Oxytocin
5%
P53
7%
Parkinson's Disease
54%
Physical Dependence
6%
Placebo
14%
Platelet
6%
Polysomnography
5%
Promoter Region
6%
Psychoactive Drug
6%
Radiation Therapy
5%
Randomized Controlled Trial
37%
Reactive Oxygen Species
7%
Sleep Disorder
16%
Sleep Quality
12%
Sleep Time
5%
Spinal Cord Injury
20%
Staining Technique
6%
Stem Cell
8%
Stereotypic Movement Disorder
7%
Striatum
8%
Subarachnoid Hemorrhage
6%
Susceptibility Weighted Imaging
6%
Temozolomide
11%
Transcranial Direct Current Stimulation
7%
Transcranial Magnetic Stimulation
13%
Traumatic Brain Injury
81%
Typical Antipsychotic
19%
Working Memory
7%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
6%
Acute Heart Infarction
7%
Adverse Event
15%
Alteplase
7%
Alzheimer's Disease
17%
Amyloid
5%
Anti-Inflammatory Drug
8%
Antidepressant
18%
Antioxidant
8%
Antipsychotic
20%
Attention Deficit Disorder
6%
Biological Marker
10%
Bipolar Disorder
34%
Brain Hemorrhage
13%
Brain Ischemia
41%
Brain Tumor
8%
Breast Cancer
6%
Cardiovascular Disease
8%
Case-Control Study
11%
Caspase 3
5%
Cell Viability
5%
Chemotherapy
9%
Chronic Kidney Failure
6%
Clinical Trial
12%
Clozapine
13%
Cognitive Defect
13%
Cohort Study
60%
Combination Therapy
11%
Comorbidity
11%
Cross-Sectional Study
6%
Cyclooxygenase 2
5%
Cytokine
6%
Cytotoxicity
5%
Deterioration
6%
Diabetes Mellitus
10%
Disease
54%
Epidermal Growth Factor Receptor
6%
Glioblastoma
41%
Head Injury
15%
Heat Stroke
6%
Histone Deacetylase Inhibitor
5%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
6%
Hyperlipidemia
6%
Infarction
6%
Infection
5%
Inflammation
20%
Injury
34%
Insulin Resistance
5%
Lipopolysaccharide
14%
Liver Cell Carcinoma
5%
Lung Cancer
5%
Major Depression
13%
Malignant Neoplasm
27%
Metabolic Syndrome X
9%
Metformin
6%
Monotherapy
7%
Mortality Rate
9%
Mouse
33%
Mouse Model
6%
Neoplasm
28%
Nervous System Inflammation
14%
Neuroprotection
7%
Neuroprotective Agent
11%
Nitric Oxide
7%
Non Insulin Dependent Diabetes Mellitus
6%
Non Small Cell Lung Cancer
6%
Olanzapine
13%
Osteoarthritis
7%
Overall Survival
5%
Parkinson's Disease
31%
Pathophysiology
6%
Pharmacotherapy
7%
Phosphotransferase
7%
Placebo
10%
Pomalidomide
6%
Prevalence
20%
Protein P53
5%
Randomized Controlled Trial
36%
Rat Model
7%
Reactive Oxygen Metabolite
10%
Recurrent Disease
8%
Remission
11%
Retrospective Study
5%
Rheumatoid Arthritis
5%
Risperidone
5%
Sarcopenia
6%
Side Effect
6%
Sleep Disorder
8%
Sleep Disordered Breathing
17%
Spinal Cord Injury
11%
Statin (Protein)
6%
Survival Rate
9%
Symptom
24%
Temozolomide
12%
Therapeutic Effect
7%
Traumatic Brain Injury
40%
Triacylglycerol
6%
Tumor Growth
5%
Tumor Necrosis Factor
7%
Typical Antipsychotic
16%